Bausch Health Companies Inc. (BHC) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Bausch Health Companies reported revenue of $10.27B, up 6.7% from $9.62B the year before. Net income was $157.0M (a 1.5% net margin), or $0.42 per diluted share. Gross margin was 17.7% and operating margin was 17.7%. Operating activities generated $1.40B of cash, leaving $1.00B of free cash flow. At fiscal year end, Bausch Health Companies held $26.37B in total assets against $25.99B in total liabilities, including $1.31B of cash and equivalents.
Open the full interactive Bausch Health Companies financials → Quarterly statements, key ratios, valuation history and price charts.
Bausch Health Companies Key Stats
| Share Price | $5.89 |
|---|---|
| Market Cap | $2.23B |
| P/E Ratio | 14.0 |
| Revenue YoY Growth | +6.7% |
| 52-Week Range | $4.43 – $7.90 |
| Shares Outstanding | 375.0 million (basic, 2026 Q2) |
Bausch Health Companies Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $8.03B | $8.43B | $8.12B | $8.76B | $9.62B | $10.27B |
| Cost of Goods Sold | $7.35B | $7.98B | $7.67B | $7.79B | $8.08B | $8.45B |
| Gross Profit | $676.0M | $450.0M | $454.0M | $963.0M | $1.55B | $1.81B |
| Operating Income | $676.0M | $450.0M | $454.0M | $963.0M | $1.55B | $1.81B |
| Pre-Tax Income | -$934.0M | -$1.02B | -$129.0M | -$390.0M | $167.0M | $367.0M |
| Income Tax | -$375.0M | -$87.0M | $83.0M | $221.0M | $239.0M | $247.0M |
| Net Income | -$560.0M | -$948.0M | -$225.0M | -$592.0M | -$46.0M | $157.0M |
| Diluted EPS | -$1.58 | -$2.64 | -$0.62 | -$1.62 | -$0.13 | $0.42 |
Bausch Health Companies Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.68B | $2.80B | $2.52B | $2.85B |
| Net Income | $179.0M | -$112.0M | -$1.42B | $258.0M |
| Diluted EPS | $0.48 | -$0.30 | -$3.82 | $0.68 |
Bausch Health Companies Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $605.0M | $582.0M | $564.0M | $947.0M | $1.18B | $1.31B |
| Current Assets | $5.34B | $5.61B | $4.25B | $5.60B | $5.77B | $6.16B |
| Total Assets | $31.20B | $29.20B | $25.69B | $27.35B | $26.52B | $26.37B |
| Current Liabilities | $4.91B | $5.20B | $3.94B | $4.30B | $6.75B | $4.18B |
| Total Long-Term Debt | $23.93B | $22.65B | $20.77B | $22.39B | $21.62B | $20.82B |
| Total Liabilities | $30.59B | $29.24B | $25.43B | $27.43B | $26.84B | $25.99B |
| Shareholders' Equity | $535.0M | -$106.0M | -$692.0M | -$1.02B | -$1.28B | -$554.0M |
Bausch Health Companies Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $1.11B | $1.43B | -$728.0M | $1.03B | $1.60B | $1.40B |
| Cash From Investing | -$261.0M | $409.0M | -$303.0M | -$2.15B | -$454.0M | -$595.0M |
| Cash From Financing | -$2.29B | -$1.51B | -$474.0M | $1.48B | -$868.0M | -$742.0M |
| Free Cash Flow | $809.0M | $1.16B | -$946.0M | $817.0M | $1.26B | $1.00B |
Figures from Bausch Health Companies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Bausch Health Companies financials page for every line item.
Bausch Health Companies Company Profile
| Ticker | BHC |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | Quebec, Quebec, Canada |
| Incorporated in | New Jersey |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000885590 |
Frequently Asked Questions
What was Bausch Health Companies' revenue in fiscal 2025?
Bausch Health Companies (BHC) reported revenue of $10.27B for fiscal 2025.
What is Bausch Health Companies' annual revenue history?
Bausch Health Companies' annual revenue by fiscal year: 2020: $8.03B; 2021: $8.43B; 2022: $8.12B; 2023: $8.76B; 2024: $9.62B; 2025: $10.27B.
What was Bausch Health Companies' net income in fiscal 2025?
Bausch Health Companies reported net income of $157.0M for fiscal 2025.
What was Bausch Health Companies' earnings per share (EPS) in fiscal 2025?
Bausch Health Companies' diluted EPS was $0.42 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Bausch Health Companies generate in fiscal 2025?
Bausch Health Companies generated $1.00B of free cash flow in fiscal 2025.
What was Bausch Health Companies' revenue last quarter?
In its most recent reported quarter (2026 Q2), Bausch Health Companies reported revenue of $2.85B.
How much debt does Bausch Health Companies have?
Bausch Health Companies reported $20.82B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Bausch Health Companies are outstanding?
Bausch Health Companies reported a weighted average of 375.0 million basic shares outstanding in 2026 Q2.
What is Bausch Health Companies' market cap?
Based on its latest closing price, Bausch Health Companies (BHC) has a market capitalization of about $2.23B.
When does Bausch Health Companies' fiscal year end?
Bausch Health Companies' fiscal year end, as registered with the SEC, is December 31.
Where is Bausch Health Companies headquartered?
Bausch Health Companies lists its business address in Quebec, Quebec, Canada in its SEC filings.